CUMBERLAND PHARMACEUTICALS (CPIX) Stock Price & Overview
NASDAQ:CPIX • US2307701092
Current stock price
The current stock price of CPIX is 3.05 USD. Today CPIX is down by 0%. In the past month the price decreased by -2.56%. In the past year, price decreased by -38.63%.
CPIX Key Statistics
- Market Cap
- 45.628M
- P/E
- 27.73
- Fwd P/E
- N/A
- EPS (TTM)
- 0.11
- Dividend Yield
- N/A
CPIX Stock Performance
CPIX Stock Chart
CPIX Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to CPIX. When comparing the yearly performance of all stocks, CPIX is a bad performer in the overall market: 90.64% of all stocks are doing better.
CPIX Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to CPIX. The financial health of CPIX is average, but there are quite some concerns on its profitability.
CPIX Earnings
On March 3, 2026 CPIX reported an EPS of -0.01 and a revenue of 13.68M.
CPIX Forecast & Estimates
CPIX Groups
Sector & Classification
CPIX Financial Highlights
Over the last trailing twelve months CPIX reported a non-GAAP Earnings per Share(EPS) of 0.11. The EPS increased by 237.5% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -3.69% | ||
| ROE | -11.4% | ||
| Debt/Equity | 0.21 |
CPIX Ownership
CPIX Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 26.35 | 853.191B | ||
| JNJ | JOHNSON & JOHNSON | 17.82 | 544.731B | ||
| MRK | MERCK & CO. INC. | 22.17 | 278.01B | ||
| PFE | PFIZER INC | 8.97 | 155.349B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 9.29 | 121.259B | ||
| ZTS | ZOETIS INC | 16.62 | 49.697B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 9.62 | 28.547B | ||
| VTRS | VIATRIS INC | 5.82 | 17.152B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 21.35 | 11.291B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 9.359B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 6.199B | ||
| TERN | TERNS PHARMACEUTICALS INC | N/A | 6.101B | ||
| CORT | CORCEPT THERAPEUTICS INC | 85.82 | 4.797B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About CPIX
Company Profile
Cumberland Pharmaceuticals, Inc. is a specialty pharmaceutical company, which focuses on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The company is headquartered in Nashville, Tennessee and currently employs 93 full-time employees. The company went IPO on 2009-08-11. The firm is focused on the acquisition, development and commercialization of branded prescription pharmaceutical products. Its portfolio of brands includes Acetadote (acetylcysteine) injection, for the treatment of acetaminophen poisoning; Caldolor (ibuprofen) injection, for the treatment of pain and fever; Kristalose (lactulose) for oral solution, a prescription laxative, for the treatment of constipation; Sancuso (granisetron) transdermal, for the prevention of nausea and vomiting in patients receiving certain types of chemotherapy treatment; Vaprisol (conivaptan) injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; and Vibativ (telavancin) injection, for the treatment of certain serious bacterial infections including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections.
Company Info
IPO: 2009-08-11
CUMBERLAND PHARMACEUTICALS
1600 West End Avenue, Suite 1300
Nashville TENNESSEE 37203 US
CEO: A. J. Kazimi
Employees: 93
Phone: 18774842700
CUMBERLAND PHARMACEUTICALS / CPIX FAQ
Can you describe the business of CUMBERLAND PHARMACEUTICALS?
Cumberland Pharmaceuticals, Inc. is a specialty pharmaceutical company, which focuses on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The company is headquartered in Nashville, Tennessee and currently employs 93 full-time employees. The company went IPO on 2009-08-11. The firm is focused on the acquisition, development and commercialization of branded prescription pharmaceutical products. Its portfolio of brands includes Acetadote (acetylcysteine) injection, for the treatment of acetaminophen poisoning; Caldolor (ibuprofen) injection, for the treatment of pain and fever; Kristalose (lactulose) for oral solution, a prescription laxative, for the treatment of constipation; Sancuso (granisetron) transdermal, for the prevention of nausea and vomiting in patients receiving certain types of chemotherapy treatment; Vaprisol (conivaptan) injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; and Vibativ (telavancin) injection, for the treatment of certain serious bacterial infections including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections.
Can you provide the latest stock price for CUMBERLAND PHARMACEUTICALS?
The current stock price of CPIX is 3.05 USD.
What is the dividend status of CUMBERLAND PHARMACEUTICALS?
CPIX does not pay a dividend.
What is the ChartMill technical and fundamental rating of CPIX stock?
CPIX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is the GICS sector and industry of CPIX stock?
CUMBERLAND PHARMACEUTICALS (CPIX) operates in the Health Care sector and the Pharmaceuticals industry.
Would investing in CUMBERLAND PHARMACEUTICALS be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on CPIX.
Can you provide the ownership details for CPIX stock?
You can find the ownership structure of CUMBERLAND PHARMACEUTICALS (CPIX) on the Ownership tab.